Medical isotope developer IsoRay of Richland, WA, announced that it has signed a deal with International Brachytherapy (IBt) of Brussels, Belgium, to form a global strategic alliance between the two firms.
The agreement will include sales and marketing in the U.S., Europe, and around the world, as well as collaborative R&D programs to develop brachytherapy sources using polymer technology associated with cesium-131 and iodine-125.
By AuntMinnie.com staff writers
September 27, 2007
Related Reading
IsoRay expands new brachytherapy plant, August 30, 2007
IsoRay to join AMEX, April 16, 2007
IsoRay continues cesium-131 placements, April 5, 2007
IsoRay scores additional financing, March 23, 2007
IsoRay adds cesium-131 sites, January 17, 2007
Copyright © 2007 AuntMinnie.com
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
